Correction: The immunogenicity and safety of an inactivated quadrivalent influenza vaccine and a 23-valent pneumococcal polysaccharide vaccine in individuals with chronic diseases. [PDF]
Frontiers Production Office.
europepmc +1 more source
Effectiveness of the 2023 Southern Hemisphere Influenza Vaccine Against Outpatient Influenza-Like Illness: A Multi-Country Test-Negative Design Study. [PDF]
Regan AK +15 more
europepmc +1 more source
Influenza vaccine uptake in juvenile idiopathic arthritis during the COVID-19 pandemic: a multi-centre cross-sectional study by PRES vaccination working party. [PDF]
Maritsi D +21 more
europepmc +1 more source
Immunogenicity and protective efficacy of an intranasal neuraminidase-based influenza vaccine with bacterial cell membrane-derived adjuvants. [PDF]
Vasilev K +8 more
europepmc +1 more source
The immunogenicity and safety of an inactivated quadrivalent influenza vaccine and a 23-valent pneumococcal polysaccharide vaccine in individuals with chronic diseases. [PDF]
Tang W +9 more
europepmc +1 more source
Assessing the Determinants of Influenza Vaccine Uptake in Malaysia: Strategies to Improve Public Health and Service Delivery. [PDF]
Manickam P +4 more
europepmc +1 more source
Smoking and serological response to influenza vaccine. [PDF]
Choi WS +7 more
europepmc +1 more source

